RxDoctor Payments Data

Mary Zingre, PA

Physician Assistant · Rockford, ILNPI 1528025848

Payments from drug & device makers

$5,207in general payments, 2019–2025

Across 255 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lundbeck LLC$738
  • Biohaven Pharmaceutical Holding Company Ltd.$541
  • Impel Pharmaceuticals Inc.$427
  • Pfizer$378
  • Biohaven Pharmaceuticals, Inc.$293
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$5,203100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,207 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$13,750
Medicare patients
69
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe77$73,660
QuliptaAtogepant41$48,914
Emgality PenGalcanezumab-Gnlm51$37,851
UbrelvyUbrogepant24$36,546
Nurtec OdtRimegepant Sulfate18$30,631
Ajovy AutoinjectorFremanezumab-Vfrm17$20,980
Diclofenac Potassium13$9,826
Sumatriptan Succinate200$5,947
Nebivolol Hcl35$3,986
Gabapentin81$1,662
Duloxetine Hcl92$1,261
Prochlorperazine Maleate65$1,257
RizatriptanRizatriptan Benzoate82$980
Nortriptyline Hcl27$775
Tizanidine Hcl73$732

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta, Ubrelvy$1,800$85,46065 claims
PfizerNurtec Odt$378$30,63118 claims
Upsher-smith Laboratories LLCTopiramate$77$24036 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →